VYGR in the 13F filings
Voyager Therapeutics Inc · CUSIP 92915B106
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 15 Aug 2024
- latest of these filings; the earliest 9 Aug 2024
- Managers listing it
- 4
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 3 listed it in both
- Shares listed
- 2,703,732
- combined, among listed positions
- Reported value
- $21m
- combined, at the quarter end
Among the 94 comparable managers: 1 buyer (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was +37,221.
Managers listing VYGR in Q2 2024
4 of 4 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Farallon Capital Management LLC | 2,292,000 | $18m | 0.08% | Held | 0 | 14 Aug 2024 (the filing on sec.gov) |
| Woodline Partners LP | 300,000 | $2.4m | under 0.1% | Held | 0 | 14 Aug 2024 (the filing on sec.gov) |
| PDT Partners LLC | 75,705 | $599k | 0.06% | New | new | 15 Aug 2024 (the filing on sec.gov) |
| Winton Group Ltd | 36,027 | $285k | under 0.1% | Trimmed | -38,484 | 9 Aug 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- PDT Partners LLCnew position · 75,705 shares now+75,705
Reductions
- Winton Group Ltdexisting position · 36,027 shares now-38,484
New positions and exits
New (1)
- PDT Partners LLC$599k
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2017 | 2 | $4.8m | n.a. | n.a. |
| Q4 2017 | 2 | $14m | n.a. | n.a. |
| Q1 2018 | 2 | $20m | n.a. | n.a. |
| Q2 2018 | 2 | $17m | n.a. | n.a. |
| Q3 2018 | 2 | $17m | n.a. | n.a. |
| Q4 2018 | 1 | $8.5m | n.a. | n.a. |
| Q1 2019 | 1 | $19m | n.a. | n.a. |
| Q2 2019 | 1 | $20m | n.a. | n.a. |
| Q2 2020 | 1 | $444k | n.a. | n.a. |
| Q3 2020 | 1 | $479k | n.a. | n.a. |
| Q4 2020 | 1 | $396k | n.a. | n.a. |
| Q1 2022 | 1 | $1.0m | n.a. | n.a. |
| Q2 2022 | 1 | $807k | n.a. | n.a. |
| Q3 2022 | 1 | $809k | n.a. | n.a. |
| Q4 2022 | 1 | $651k | n.a. | n.a. |
| Q1 2023 | 3 | $12m | n.a. | n.a. |
| Q2 2023 | 3 | $23m | n.a. | n.a. |
| Q3 2023 | 3 | $15m | n.a. | n.a. |
| Q4 2023 | 2 | $11m | 0 | 1 |
| Q1 2024 | 3 | $25m | 3 | 0 |
| Q2 2024 | 4 | $21m | 1 | 1 |
| Q3 2024 | 1 | $13m | 0 | 0 |
| Q4 2024 | 1 | $15m | 1 | 0 |
| Q1 2025 | 1 | $8.7m | 0 | 0 |
| Q2 2025 | 1 | $2.2m | 0 | 1 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VYGR and GILD →VYGR and AMGN →VYGR and ARGX →Choose a stock to compare with VYGR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VYGR, latest filings →Back to the 13F Explorer →